Yahoo · Aug 20, 2026
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
European equities traded in the US as American depositary receipts were tracking higher late Thursda
DB
NASDAQ · DBVT
DBV Technologies S.A.
Healthcare · Biotechnology
$13.54
Up+$0.25 (+1.81%)
Updated Aug 31, 2026, 6:51 PM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 464.56M
- P/E ratio
- -4.18
- Dividend yield
- 0.00%
- 52-week range
- $13.00 – $24.05
- Volume
- 146.15K
- Avg. volume
- 215.76K
Price performance
DBVT price history
1M range · 0 trading sessions · Daily adjusted prices
DBVT does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest DBVT news
The latest Smart Investors Daily articles mentioning DBVT.
Stock researchCompany · Overview
DBVT research
Overview
Company profile and research snapshot.
Company profile
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $35.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 17, 2024 | PORTZAMPARC BNP PARIBAS | Buy | — |
| Jun 16, 2024 | PORTZAMPARC BNP PARIBAS | Buy | — |
| Mar 14, 2024 | SOCIETE GENERALE | Buy | — |
| Mar 13, 2024 | SOCIETE GENERALE | Buy | — |
| Dec 19, 2023 | PORTZAMPARC BNP PARIBAS | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Aug 17, 2026
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading
European equities traded in the US as American depositary receipts started the week tracking modestl
Yahoo · Aug 14, 2026
European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading
European equities traded in the US as American depositary receipts were tracking lower late Friday m
SeekingAlpha · Jul 26, 2026
DBV Technologies: Regulatory Noise, Commercial Misperception, And A Deep Valuation Gap
DBV Technologies is engaged in a race against the clock to file its first BLA, get it approved, and start commercialization. See why I rate DBVT stock a Buy.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
